Background and Aims: Oral sodium phosphate solution (OSPS) is an effective agent for preparing the bowel prior to colonoscopy (C) examination. However, rare cases of nephrocalcinosis have been associated with the use of OSPS. Of the 21 cases reported in a retrospective series by Markowitz et al (J A Soc Nephrol 2005; 16: 3389) and of the 5 cases reported by Ori et al (A J Med Sci 2008; 336: 309), 80% were female. Thus gender may be a risk factor for phosphate induced nephropathy. However, there have been no randomized, prospective studies carried out to study this issue. Methods: Female (F) and male (M) subjects requiring C were randomized to receive either OSPS or PEG for bowel preparation. OSPS (Fleets PhosphoSoda) was given in 2 doses of 45 ml each, the day prior to C and on the morning of procedure. Adequate hydration was stressed. 240 ml of PEG (Colyte) was given every 10 minutes until 4L were ingested the night prior to C. Renal toxicity was assessed by measuring serum creatinine (Cr, mg/dL), GFR, (ml/min) and spot urine NAG (IU/mg cr) (N-acetyl-D-glucosamine is a urinary enzyme which increases after renal tubular injury) one week prior to, on the day of and one week after C. The efficacy of the bowel preparation was assessed using the Ottawa Score (OS, 0-14), the time to reach cecum and the number of polyps detected. Results: Twenty F and 40 M subjects completed the study. The mean age of F and M subjects was 52 ± 9 y and 54 ± 6 y, respectively. Of the 60 subjects, 42 received OSPS (14 F+ 28 M) and 18 received PEG (6 F+ 12 M). Administration of OSPS did not cause any significant difference in the % change in Cr (-7.2%, + 2.2%, P= 0.7 in F and M, respectively), % change in eGFR (+1%, +12%, P=0.12 in F and M, respectively) and urinary excretion of NAG (+2%, -7%, P=0.7 in F and M, respectively) when compared to baseline. Additionally, these parameters were not altered 1 week post C. Similarly, administration of the PEG did not make a significant difference in % change in either Cr or eGFR or urinary NAG excretion in either M or F subjects when compared to baseline. Bowel cleansing with both OSPS and PEG produced acceptable preparations (OS < 3 irrespective of gender). Furthermore, the time to reach the cecum (PEG 14 ± 3 min, OSPS 18 ± 4 min) and the number of polyps removed were not statistically different irrespective of the bowel preparations employed in both gender groups. Conclusion: In this prospective, randomized study, there was no clinically significant renal toxicity when comparing M and F subjects regardless of the type of C preparation. The present study, however, was not powered to detect idiosyncratic events of renal toxicity.
Read full abstract